Education
About Us
Working with TipRanks
Follow Us
Regenicin Inc (RGIN)
OTHER OTC:RGIN
RGIN Stock Chart & Stats
$0.01
<$0.01(9900.00%)
At close: 4:00 PM EST
$0.01
<$0.01(9900.00%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.01
Previous CloseN/A
Volume10.00K
Average Volume (3M)2.50K
Market Cap
$15.35K
Enterprise ValueN/A
Total Cash (Recent Filing)$11.86M
Total Debt (Recent Filing)$642.92K
Price to Earnings (P/E)―
Beta-44.54
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding153,483,050
10 Day Avg. Volume2,500
30 Day Avg. Volume2,500
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)-0.09
Price to Sales (P/S)0.00
P/FCF Ratio-18.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
RGIN FAQ
What was Regenicin Inc’s price range in the past 12 months?
Regenicin Inc lowest stock price was <$0.01 and its highest was $0.01 in the past 12 months.
What is Regenicin Inc’s market cap?
Regenicin Inc’s market cap is $15.35K.
When is Regenicin Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Regenicin Inc’s earnings last quarter?
Currently, no data Available
Is Regenicin Inc overvalued?
According to Wall Street analysts Regenicin Inc’s price is currently Overvalued.
Does Regenicin Inc pay dividends?
Regenicin Inc does not currently pay dividends.
What is Regenicin Inc’s EPS estimate?
Regenicin Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Regenicin Inc have?
Regenicin Inc has 153,483,050 shares outstanding.
What happened to Regenicin Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Regenicin Inc?
Currently, no hedge funds are holding shares in RGIN
Company Description
Regenicin Inc
Regenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. The company's product portfolio includes NovaDerm, a multi-layered tissue-engineered living skin and cultured skin substitute product for the treatment of burns; and TempaDerm to treat smaller wound areas on patients, such as ulcers. Its products are used to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds, and various plastic surgery procedures. The company was formerly known as Windstar, Inc. and changed its name to Regenicin, Inc. in July 2010. Regenicin, Inc. was incorporated in 2007 and is headquartered in Little Falls, New Jersey.
Technical Analysis
Biodexa Pharmaceuticals
―
Salarius Pharmaceuticals
―
Quoin Pharmaceuticals
―
Processa Pharmaceuticals
―
GRI Bio
―
Ownership Overview
―
Insiders
―
Mutual Funds
0.05% Other Institutional Investors
99.95% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---